Role of Immunoscore® in Stage II-III Colorectal Cancer

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2023

Conditions
Colon Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

Immunoscore Colon Test

Immunoscore® is a tissue-based immune test that measures the host's immune response at the site of the tumor. It is performed on formalin-fixed paraffin-embedded (FFPE) tumor tissue samples from resections of localized colon cancer. The test uses whole slide imaging and artificial intelligence algorithms for assessment of the type, density, and location of T cells in FFPE tumor sections to determine an individual Immunoscore® for each patient.

Trial Locations (2)

Unknown

RECRUITING

Instituto D'Or de Pesquisa e Ensino - Brasília, Brasília

RECRUITING

Instituto D'Or de Pesquisa e Ensino - Rio de Janeiro, Rio de Janeiro

Sponsors
All Listed Sponsors
collaborator

HalioDx

INDUSTRY

collaborator

Diagnosticos da America SA

UNKNOWN

lead

D'Or Institute for Research and Education

OTHER

NCT05422547 - Role of Immunoscore® in Stage II-III Colorectal Cancer | Biotech Hunter | Biotech Hunter